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Magnus Sko¨lda,, Per Bakkeb, Johnny Kongerudc, Thomas RingbækdaDepartment of Medicine, Karolinska Hospital, Stockholm, Sweden
bDepartment of Respiratory Medicine, Haukeland University Hospital, Oslo, Norway
cDepartment of Respiratory Medicine, University Hospital Oslo, Norway
dDepartment of Medicine, Hvidovre Hospital, Denmark
’ ’The first Scandinavian COPD Research Sympo-
sium’’ was held at Holmenkollen Park Hotel Rica,
Oslo, Norway, November 11–12, 2004. The purpose
of the meeting was to let young scientists from
Denmark, Norway and Sweden come together and
present their current COPD-related research. In
addition, the meeting should facilitate collabora-
tion and stimulate further research in the field of
COPD within the Scandinavian countries. Eleven
young Scandinavian scientists had oral presenta-
tions and presented their latest data and four
State-of-the-Art lecturer covered two sessions
’ ’
Inflammation and structural changes in COPD’’
and
’ ’
Epidemiological and work-related COPD’’.
The meeting was generously supported by grants
from Boehringer-Ingelheim and Pfizer.
ABSTRACTS—STATE OF THE ART
Inflammation in COPD
K.F. Rabe
Department of Pulmonology, C3-P, Leiden Univer-
sity Medical Center, Albinusdreef 2, 2333 ZA
Leiden, The Netherlands
E-mail address: K.F.Rabe@lumc.nlee front matter & 2005 Elsevier Ltd. All rights reserv
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esses: magnus.skold@medks.ki.se (M. Sko¨ld),
e-bergen.no (P. Bakke), johny.kongerud@
o (J. Kongerud), ringbaek@stofanet.dkCOPD is a heterogeneous disorder comprising of
different components such as chronic bronchitis,
small airway obstruction and emphysema. Recent
evidence suggests that the inflammatory changes
observed in this disease vary specifically from those
observed in asthma and much progress has been
made in the understanding of this inflammatory
process that will have to lead to the identification
of novel therapeutic targets.
In chronic bronchitis inflammation is primarily
located in the epithelium of the central airways
and extends along the ducts of the mucus producing
glands. Inflammatory cells from the innate and
adaptive host defence participate in this process.
Chronic bronchitis is associated with changes in
bronchial wall thickness, which is believed to be
related to an increase in connective tissue deposi-
tion. At present it is not quite clear what the risk
factors are that contribute would contribute to the
progression from chronic bronchitis to the clinical
state of COPD. It seems likely, however, that
repeated respiratory tract infections in smokers
will contribute to a more rapid fall in FEV1 over
time.
The site of airflow obstruction in chronic
bronchitis is in principle the smaller conducting
airway. Several studies have demonstrated struc-
tural abnormalities and these, according to very
recent data, seem to be related to the severity
of COPD.
Ongoing inflammation and the increase of tissue
between the airway smooth muscle and airway walled.
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will increase resistance. The notion that a sizeable
number of individuals with COPD exhibit airway
hyperresponsiveness may be due to a combination
of structural changes in the peripheral lung and
genuine smooth muscle abnormalities.
Several reports have shown that B-cells, CD4-
and CD8-lymphocytes are present in the airway
tissue of patients with COPD and the rate decline of
FEV1 seems to be related to increases in CD8-cells
and B-cells. At present it is unclear whether the
presence of CD8-cells is related to the involvement
of the adaptive immune response or whether it is
driven by microbial colonisation. Notably, available
treatment strategies with bronchodilators and
corticosteroids do not affect CD8-cells in the
airway in patients with COPD.
Lung emphysema is defined by dilatation destruc-
tion of lung tissue beyond the terminal bronchioles
and there is a rough correlation between the
presence of emphysema and pack years of smoking
in patients with COPD. Notably, small peripheral
airways in patients with severe emphysema also
exhibit significant inflammatory changes and signs
of airway remodelling. Inflammation in COPD is a
complex process that involves the large and
particularly the small airways. Current strategies
of symptomatic treatment in combination with
inhaled corticosteroids most likely have a limited
impact on a variety of those inflammatory changes
so that novel targets need to be identified.
Structural changes in COPD
Marina Saetta, Simonetta Baraldo, Bianca Beghe´,
Graziella Turato, Renzo Zuin
Department of Respiratory Diseases, University of
Padova, via Giustiniani 3, 35128 Padova, ITALY
E-mail address: marina.saetta@unipd.it
Chronic obstructive pulmonary disease (COPD) is a
public health problem worldwide, being a major
cause of chronic morbidity and mortality. According
to the most recent guidelines, COPD is defined as a
preventable and treatable disease state charac-
terised by not fully reversible airflow limitation
that is usually both progressive and associated with
an abnormal inflammatory response of the lungs to
noxious particles or gases. The chronic airflow
limitation characteristic of COPD is caused by a
mixture of small airway disease (bronchiolitis) and
parenchymal destruction (emphysema), the rela-
tive contributions of which vary from person to
person. In fact, since expiratory flow is the result of
a driving pressure that promotes flow (elastic recoilof the lung parenchyma), and of an opposing
resistance that contrasts flow (obstruction of
peripheral airways), a reduction in flow can occur
either by reducing the driving pressure or by
increasing the resistance. In smokers, the patholo-
gical changes involving the peripheral airways will
contribute to airflow limitation by narrowing and
obliterating the lumen and by actively constricting
the airways, therefore increasing the resistance.
These pathological lesions include airway wall
inflammation, fibrosis, increased smooth muscle
mass and goblet cell metaplasia. Goblet cell
metaplasia may produce an excess of mucus which
could obstruct the lumen and alter the surface
tension of the airway lining fluid, rendering the
peripheral airways unstable and facilitating their
closure. Inflammation, fibrosis and increased
smooth muscle mass, by increasing the thickness
of the airway wall, may facilitate uncoupling
between airways and parenchyma and promote
airway narrowing. In addition, airway wall inflam-
mation could contribute to the destruction of
alveolar walls which attach to the airways,
allowing the airway wall to deform and narrowing
the airway lumen. Interestingly, it has been
recently shown that these structural changes
induce a marked thickening of the airway wall
which progressively increases as COPD progresses
from GOLD stage 0 to GOLD stage 4, suggesting a
key role for airway wall thickening in the severity
of the disease.
COPD due to occupational exposures
P. Sherwood Burge
Occupational Lung Disease Unit, Birmingham
Heartlands Hospital, Birmingham B9 5SS, UK
E-mail address: sherwood.burge@heartsol.wmids.
nhs.uk
About 15–20% of the risks for COPD can be
attributed to occupational exposures. These figures
are derived from population studies, many of which
were instigated to investigate air pollution or
cardiovascular risks. Workers starting in dusty
occupations have better lung function than those
starting in cleaner jobs, using cross-sectional
studies the effect of the working exposure are
then only apparent in older workers.
There is consistent evidence that workers in
dusty occupations have more cough and sputum
(chronic bronchitis), and an increased rate of FEV1
decline (leading to COPD), than workers without
dust or fume exposure. Some studies suggest that
fume exposure is responsible for less COPD than
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smokers than non-smokers.
Studies on silica exposed workers suggest that
silica is a particularly potent cause of COPD. The
risk are increased by silica exposure independently
of any silicosis, as those with a normal chest X-ray
have similar COPD to those with simple silicosis.
The risks are enhanced by cigarette smoking. For
similar levels of exposure coal dust is a much
weaker cause of COPD.
Cadmium exposure is the only chemical with a
clear relationship with emphysema, although silica
exposure also probably exerts much of its effect by
causing emphysema.
Economic burden of COPD
Jørgen Vestbo
North West Lung Centre, South Manchester Uni-
versity Hospital, Manchester, UK
E-mail address: jvestbo@man.ac.uk
The costs of COPD are significant but often difficult
to ascertain. Several studies have estimated both
direct medical expenditures and the indirect costs
of morbidity and premature mortality from COPD.
The direct cost is the value of health care
resources devoted to diagnosis and medical man-
agement of the disease and as examples these costs
has been estimated to be app. $15 billion in the US
and £850 million in the UK. When calculated per
patient the direct costs vary markedly. The
majority of the direct costs relate to treatment of
patients with severe COPD; roughly said, 20% of
patients account for 80% of costs. In general
exacerbations seem to be the cost driver, not least
when hospital admission is needed. Indirect costs
reflect the monetary consequences of disability,
missed work and school, premature mortality, and
caregiver or family costs resulting from the illness
and these costs are much more difficult—and often
impossible—to calculate.
Additionally, several sources of underestimation
exist. Basically, cost figures depend on diagnoses
and the widespread underdiagnosis of COPD in-
variably leads to underestimation of costs, an
example being exacerbations of undiagnosed COPD
registered as bronchitis, lower respiratory tract
infection, or in the winter season ‘influenza’. Early
retirement from the workforce is often not attrib-
uted to COPD, and with increasing home care in
COPD it is likely that the hidden costs from
carers taking part in the treatment will be under-
estimated.ABSTRACTS—OTHER LECTURES
Associations between plasma folate, plasma total
homocysteine and airflow obstruction in a cross-
sectional community study of middle-aged and
elderly
S. Lehmanna, S.E. Vollsetb, P.S. Bakkea,
H. Refsumc,d, P.M. Uelandb, A. Gulsvika
aDepartment of Thoracic Medicine, Institute of
Medicine
bLOCUS for Homocysteine and Related Vitamins
cDepartment of Pharmacology, University of
Bergen, Norway
dDepartment of Pharmacology, University of
Oxford, UK
E-mail address: sverre.lehmann@helse-bergen.no
The total plasma homocysteine (tHcy) is a strong
predictor for occlusive vascular disease, cardiovas-
cular events in coronary heart disease and
cardiovascular mortality. Folate has many funda-
mental properties, such as 1-carbon transfers in
DNA and RNA synthesis. It also lowers the blood
levels of homocysteine. The airways’ defence
mechanisms working against the development
of irreversible airflow obstruction may benefit
from high levels of folate and low levels of
homocysteine.
Aim: To determine whether plasma levels of folate
and tHcy are correlated with obstructive airflow
limitation in an adult general population.
Method: An age-gender stratified random sample
of women and men 47–48 and 71–73 years old
were invited to bronchodilator reversibility test.
The level of airflow obstruction was expressed
as FEV1/FVC% (post-bronchodilator FEV1/FVC
100(%)). Non-fasting blood samples and self-admi-
nistered questionnaires were collected.
Results: 3506 subjects participated (69%). In a
linear multiple regression analysis adjusted for age,
sex, smoking and educational level the difference
in FEV1/FVC ratio between individuals with folate
above and below the median was 0.48% (95%CI
0.01–0.95, P ¼ 0.044). In a similar analysis
there was no difference in FEV1/FVC ratio
between individuals with tHcy above and below
the median.
Conclusion: A high level of plasma folate is
associated with less obstructed airflow in middle-
aged and elderly from a general Norwegian
population.
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after segmental endotoxin exposure in human
airways
I. Qvarfordta, M. Smith, C. Malmha¨lla,
M. Sjo¨stranda, S. Bozinovskib, G.P. Andersonb,
A. Linde´na,b
aRespiratory Medicine and Allergology, University
of Go¨teborg, Sweden
bCRC-CID, Departments of Pharmacology and
Medicine, University of Melbourne, Australia
E-mail adress: ingemar.qvarfordt@lungall.gu.se
Tissue degradation is a hallmark of COPD. This
phenomenon may in part relate to the local
accumulation of neutrophils, releasing tissue-de-
grading proteases. In this process, endotoxin (LPS)
from tobacco smoke or gram-negative bacterial
colonisation may act as co-stimuli for neutrophil
responses. In our ongoing study on human volun-
teers, we characterise the time course and locali-
sation of cellular and mediator changes after
airway exposure to endotoxin.
Broncoscopy is utilised to segmentally expose
healthy subjects to LPS, with contralateral saline as
control. Bronchoalveolar lavage fluid (BALF) is
collected at different time points thereafter. BALF
and blood will be analysed for cellular changes, as
well as changes in concentration and activity of
soluble mediators. For this preliminary report,
BALF from 6 subjects was collected 48 h after LPS
exposure and analysed for cellular content (mor-
phology) and MMP-9 concentration (ELISA). Immu-
no-cytochemistry (ICC) for MMP-9 was performed
on BALF cytospins.
Total cell, neutrophil and MMP-9 concentrations
were significantly higher in the LPS-exposed than in
the control segment. MMP-9 ICC indicated neutro-
phils as the dominant cellular source.
In conclusion, endotoxin causes unilateral neu-
trophil accumulation and MMP-9 release in human
airways. Thus, the mobilisation of the main effector
cell in innate immunity is strictly compartmenta-
lised. The cellular events behind this will be further
explored during the continuation of this study.
This study receives financial support from the
Swedish Heart Lung Foundation and the Swedish
Research Council.
Bronchoalveolar lavage (BAL) in COPD: fluid
recovery and macrophage phenotype
Magnus Lo¨fdahl, Kerstin Cederlund, Lennart
Nathell, Johan Grunewald, Anders Eklund,
Magnus Sko¨ldDepartment of Medicine, Div Respiratory Medicine,
Karolinska Institutet, Stockholm, Sweden
E-mail adress: magnus.lofdahl@karolinska.se
COPD is a heterogeneous disorder affecting both
large and small airways as well as the lung
parenchyma. The predominant BAL cell type in
COPD is the alveolar macrophage (AM). These cells
have functions that potentially could contribute to
the pathogenesis of the disease. We hypothesised
that AM from COPD patients have an altered
phenotype compared to controls.
Bronchoscopy and BAL was performed on 20
COPD patients (mean age 57) with a median FEV1
of 51% of predicted.
’ ’
Healthy’’ smokers and non-
smokers served as controls. Macrophage phenotype
was analysed with flow cytometry. The COPD
patients had their degree of emphysema scored
on CT-scan.
BAL fluid return was significantly lower in COPD
compared to controls (Po0.001), and it correlated
to the degree of emphysema and diffusion capacity
for carbon monoxide (DLCO) but not to FEV1. Cell
concentration was higher in COPD and smokers. The
co-stimulatory molecule CD 86 and the adhesion
molecule CD 11a had a lower expression on AM from
COPD compared to smokers whereas CD 11c was
increased in COPD and smokers. CD 54 was lower in
smokes vs. non-smokers.
We conclude that emphysema assessment on CT-
scan may be a useful tool for predicting BAL
recovery in COPD. The altered AM phenotype in
COPD may be a marker of disease development, but
may also be an effect of smoking per se.
The immune system in the lungs of patients with
COPD
Astrid Norgaard
Department of Clinical Immunology, Copenhagen
University Hospital, Copenhagen, Denmark
E-mail address: astrid.norgaard@dadlnet.dk
The innate and the adaptive immune systems
integrate and reinforce one another during hand-
ling of infections and other immune reactions. In
COPD, both systems are involved, and accumulating
evidence indicates that T-cells, in particular cyto-
toxic CD8 memory cells are responsible for the
ongoing tissue damage. It is theorised that these T-
cells are activated by an unusual antigen (possibly a
tissue antigen resulting from neutrophil and macro-
phage activity) and that they home specifically to
the bronchial mucosa, maintaining chronic inflam-
mation here. Recent studies support the theory
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the regional paratracheal lymph nodes in parallel
to the highly specific homing mechanisms demon-
strated in other immune regions such as the skin
and gut. It is believed that unique bronchial homing
molecules do exist in humans, but though such
molecules have been identified in the human skin
and gut, and a unique lungkine was found in the
bronchi of mice, such molecules have not yet been
demonstrated in human lung. We have established
a flowcytometric method for bronchial lavage (BL)
fluid and are currently investigating T-cells from
patients with moderate COPD, comparing a combi-
nation of homing molecules (primarily CD103,
CD69, CD49a, HLA-DR, CD62L, CXCR6, CD45RO/
RA) between BL fluid and peripheral blood. The
purpose of this is to identify the memory intrae-
pithelial CD8 T-cells and to search for a unique lung
homing profile of these T-cells to the bronchi. With
such knowledge it will be possible to design drugs
to dampen the T-cell controlled inflammation and
lead the way to the understanding of the pathologic
process of COPD.
Airway inflammation in bronchial mucosa and
bronchoalveolar lavage in COPD
Anders Blomberg
Department of Respiratory Medicine and Allergy,
University Hospital, Umea˚, Sweden
E-mail address: anders.blomberg@lung.umu.se
CD4+ and CD8+ T cells have been suggested to play
a central role in the inflammatory response in
chronic obstructive pulmonary disease (COPD).
In the present study, airway T cell subsets were
determined in individuals with moderate to severe
COPD (FEV1 46; 33–51% predicted, age 67; 60–75)
and compared to age-matched healthy controls.
Compared to healthy, COPD-patients had higher
percentages of airway CD8+ T cells, T cells expres-
sing the g=d-receptor (TCRg=d-cells) and NK cells
(CD15+/56+). In contrast, CD4+ T cells and the
CD4+/CD8+-ratio were decreased. In COPD-pa-
tients, CD8+ T-cells were activated as shown by
an increased expression of CD69+ and CD25+. Also,
CD4+ T cells displayed increased CD25+ expression,
indicating presence of regulatory T cells.
In another study, staining of endobronchial
biopsies from a similar group of COPD-patients
and healthy controls, revealed an increase in the
number of both CD4+ and CD8+ Tcells the bronchial
epithelium, compared to healthy subjects.
The present data imply a difference in T
lymphocyte subsets between individuals with COPDand healthy. COPD patients have more CD8+ T cells
in the lower airways and a higher percentage of
these cells are activated, whereas epithelial
numbers of both CD4+ and CD8+ T cells are
enhanced. Taken together, these finding support
the contention that T cells are of importance in the
pathogenesis of COPD.
Quantitative computed tomography is more sen-
sitive than lung function tests in monitoring the
progression of emphysema
Saher B. Shaker, Lars C. Laursen, Asger Dirksen
Department of Respiratory Medicine, Gentofte
Hospital, DK-2900 Hellerup, Denmark
E-mail address: SASHA@gentoftehosp.kbhamt.dk
Introduction: We studied the potential of quanti-
tative computed tomography (CT) of the lung to
monitor the progression of emphysema in compar-
ison with lung function tests (LFT). For this
purpose, the 15th percentile density (PD15) was
used as a CT-parameter and forced expiratory
volume in one second (FEV1) and diffusion capacity
(DLCO) were used as LFT-parameters.
Materials and methods: The study population
was comprised of 34 patients with emphysema: 17
with smoker’s emphysema and 17 with alpha-1
antitrypsin deficiency (A1AD). Comprehensive
LFTs and quantitative CT were performed on 2
occasions with a 3-year interval. The annual
change in FEV1, DLCO and PD15 was calculated
and expressed as disease-specific annual fall by
subtracting the normal annual fall. Then a sensi-
tivity score for monitoring the progression of
emphysema was calculated as the ratio between
the annual fall and the standard deviation of
repeated measurements and compared for the 3
parameters.
Results: In patients with smoker’s emphysema, the
disease-specific annual fall in FEV1, DLCO and PD15
was 37ml (95% confidence interval [CI] 3–72),
0.05mmol/min/kPa (CI 0.13–0.22) and 2.3 g/l
(CI 1.5–3.1), respectively. In patients with AATD,
the disease-specific annual fall in FEV1, DLCO and
PD15 was 46 (CI 19–73), 0.16 (CI 0.00–0.33) and 2.2
(CI 1.5–2.8), respectively. The sensitivity of FEV1,
DLCO and PD15 to monitor the progression of
emphysema in smoker’s emphysema was 0.26,
0.07 and 0.59, respectively. The sensitivity of
FEV1, DLCO and PD15 to monitor the progression of
emphysema in A1AD was 0.41, 0.24 and 0.67,
respectively.
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FEV1 and more than twice as sensitive as DLCO to
monitor the progression of emphysema in both
smoker’s emphysema and emphysema due to A1AD.
Hyperinflation in COPD: From physiology to
perception and back again
Finn V. Rasmussen
Department of Respiratory Medicine, Medical Unit
II, Hillerod Hospital, DK 3400, Denmark
E-mail address: fvr.sip@adr.dk
The concept of hyperinflation and its relationship
with dyspnea in patients with emphysema is
described in the medical literature more than 150
years ago. Its clinical importance has, however
been neglected until its revival during the last 10
years or so.
With the introduction of dynamic spirometry and
measurement of FEV1 and FVC as diagnostic tools in
asthma and COPD it was for many years believed
that reversibility of airways obstruction, demon-
strated as increase in expiratory flow rates and
FEV1, was the prerequisite for treatment with
bronchodilating drugs. However, it has been de-
monstrated that there is no significant relationship
between changes in FEV1 after bronchodilator
drugs and the patients preference for continued
treatment with the drug. Methods to measure
the perception of dyspnea quantitatively were
developed, and it was realised the correlation
between measures of maximal expiratory flows,
included FEV1 and the perception of dyspnea
was poor.
The interest in lung mechanics and resting lung
volumes was revived and it has been shown that
inspiratory work load was the major contributor to
development of dyspnea and that hyperinflation
due to incomplete expiration was the physiological
mechanism behind this phenomenon.
Measurements of inspiratory capacity, IC, at rest
and during exercise as well as before and after
bronchodilating drugs is the simple and straight
forward way of demonstrating this.
So we have gone from forced expiratory man-
oeuvres to perception of dyspnea and back again to
clinical respiratory physiology with focus on in-
spiratory manoeuvres and resting lung volumes.
Occupational airborne exposure and the inci-
dence of respiratory symptoms in a general
population
Trude Dueliena,baInstitute of Medicine, University of Bergen, Nor-
way
bDepartment of Thoracic Medicine, Haukeland
University Hospital, Bergen, Norway
E-mail address: tduelien@online.no
Background: Several prevalence studies have sug-
gested an association between occupational ex-
posure and respiratory symptoms, but there has
been a lack of incidence studies to verify this.
Methods: This study examined the incidence of
respiratory symptoms in an 11-year Norwegian
community cohort study with 2819 subjects.
Predictors examined were sex, age, educational
level, lifetime exposure to quartz, asbestos, and
dust or fumes, as well as smoking habits and pack-
years.
Results: The prevalence of exposure to quartz,
asbestos, and dust or fumes was, respectively,
3.7%, 5.0%, and 28.3% at baseline. The cumulative
11-year incidence of respiratory symptoms ranged
from 6.2% for dyspnea grade 3–29.1% for wheezing
in subjects exposed to dust or fumes. The corre-
sponding incidence of respiratory symptoms in
those not exposed ranged from 3.9% (dyspnea
grade 3) to 24.7% (wheezing). For those exposed
to dust or fumes the odds ratios (95% confidence
intervals) varied between 1.4 (1.1,1.7) and 2.1
(1.3,3.2) for developing respiratory symptoms after
adjusting for sex, age, educational level, and
smoking.
Between 5.7% and 19.3% of the incidence of
respiratory symptoms were attributable to dust or
fumes exposure after adjustment for sex, age,
educational level, and smoking.
COPD and occupation—Danish initiatives
Ø. Omlanda,b, V. Schlu¨nssena,b, S.W. Christensena,
J.G. Hansenc, T. Sigsgaardb
aDepartment of Occupational Medicine, Aalborg
Hospital, A˚rhus University Hospital, Aalborg, Den-
mark
bInstitute of Occupational and Environmental
Medicine, University of A˚rhus, A˚rhus, Denmark
cDepartment of Clinical Epidemiology, Aalborg
Hospital, A˚rhus University Hospital, Aalborg, Den-
mark
E-mail address: om@aas.nja.dk
Objective: To present Danish epidemiological stu-
dies designed to look for associations between work
exposure and COPD.
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studies will be presented: A follow up of 135
persons 79 welders and 56 controls, in 1987 aged 32
to 35 years. All subjects have been invited to a new
investigation comprising of a questionnaire, lung
function measurements and blood samples. Histor-
ical exposure measurements are available.
A prospective cohort study comprising of 2.033
woodworkers and 474 controls is conducted to
investigate the relation between wood dust ex-
posure and respiratory impairment. In 1997–1998
and 2003–2004 data were collected on respiratory
symptoms and smoking, lung function, and wood
dust exposure based on personal dust measure-
ments.
A prospective population based study in two
counties where all GPs are invited. The sample will
be 8.500 adults from the practises. The aim is to
describe the prevalence at baseline, to study
factors associated to increased risk, and measure
the incidence. Data will consist of answers from
questionnaire including work exposure, lung func-
tion, and blood samples.
Conclusion: Ongoing Danish studies indicate a new
focus on an old problem, and they might help to
elucidate the actual etiological fraction of work on
COPD.
COPD in tunnel workers
Bente Ulvestada, May Brit Lundb
aDepartment of Occupational Medicine, Mesta AS,
Lysaker, Norway
bDepartment of Thoracic Medicine, The National
Hospital, University of Oslo, Norway
E-mail address: bente.ulvestad@mesta.no
As tunnel workers are exposed to gases and
particles from drilling, blasting and diesel exhausts,
we aimed to assess the occurrence of respiratory
symptoms and lung function decline and relate
these findings to exposure.
Two hundred and twenty one tunnel workers and
a reference group of 205 outdoor construction
workers participated in a cross-sectional study.
Respiratory symptoms and lung function were
studied in relation to years of exposure.
Secondly 29 non-smokers, who had worked in a
tunnel for 1 year, were examined by acoustic
rhinometry, exhaled nitric oxide and spirometry.
Finally 122 tunnel workers were included in a
prospective study, and were re-examined 8 years
later. Cumulative exposure to dust and gases was
estimated.Among 212 tunnel workers the prevalence of
COPD was 14%. Compared to the reference sub-
jects, the tunnel workers had a significant decrease
in FEV1, when related to years of exposure.
Tunnel workers who had worked underground for
1 year had increased occurrences of respiratory
symptoms, nasal mucosal swelling and increased
exhaled NO-levels.
It was predicted that in a worker 40 years of age,
the annual decrease in FEV1 would be 25ml in a
non-exposed non-smoker, 35ml in a non-exposed
smoker, and 50–63ml in a non-smoking tunnel
worker (depending on job tasks). Cumulative
exposure to respirable dust and nitrogen dioxide
seemed to be the major risk factors.
Chronic obstructive pulmonary disease and socio-
economic factors in cross-sectional and long-
itudinal studies
Anne Lindberga,b, Lars-Gunnar Larssona,b,
Eva Ro¨nmarka,c, Bo Lundba¨cka,c
aThe OLIN Studies, Sunderby Central Hospital of
Norrbotten, Lulea˚
bDivision of Respiratory Medicine and Allergy,
Department of Medicine, Sunderby Central Hospi-
tal of Norrbotten, Lulea˚
cLung and Allergy Research, National Institute of
Environmental Medicine, Karolinska Institutet,
Stockholm, Sweden
E-mail address: anne.lindberg@algmed.se
Most current knowledge of Chronic Obstructive
Pulmonary Disease (COPD) originates from cross-
sectional studies. There is data on the prevalence
of COPD in the general population mostly in the
range of 4–10%. It is well-known that age and
smoking habits of the studied populations, but also
the spirometric criteria of COPD, will affect the
prevalence. Cross-sectional studies have provided
data also on other factors associated with prevalent
disease, among others socio-economic status and
occupational airborne exposure. According to some
authors socio-economic factors are next to smoking
the most important modifiable risk factors for
COPD.
There are, however, sparse data on COPD from
longitudinal studies. Only a few reports on the
incidence of COPD are found in the literature, and
consequently data on risk factors for incident
disease are sparse.
Smoking is a possible preventable risk factor.
Socio-economic factors and occupational airborne
exposure are also factors that are impressionable.
After smoking cessation, or among non-smokers,
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Further analyses, especially in longitudinal studies,
are needed to evaluate the relationship between
socio-economic factors and occupational airborne
exposure and development of COPD.
Early detection of COPD in primary care: Invita-
tion of smokers, 40–55 years old
Georgios Stratelis
Institution of Health and Society, University Hospi-
tal, Linkoping, Sweden
E-mail address: georgios.stratelis@lio.se
Background: The incidence of chronic obstructive
pulmonary disease (COPD) is increasing in devel-
oped countries, as is the mortality rate. The main
cause of COPD is smoking and COPD is usually
diagnosed in the later stages of its course.
Aims: To evaluate a method to detect COPD at an
early stage in a young age group (40–55 years) of
smokers.Design: Smokers, 40–55 years old, were invited to
perform a free spirometry in Primary care. Adver-
tisements were put in local media four a year.
Setting: City of Motala (45 000 inhabitants) and its
surrounding rural areas (43 000 inhabitants) in
Southeast Sweden. In the age group 40–55 there
were 19 750 subjects. According to Swedish statis-
tics approximately 27% of this population are
smokers.
Results: A total of 512 smokers responded. The
prevalence of COPD as defined by GOLD was 29%
ðn ¼ 150Þ. The COPD was classified as stage I in 63%
ðn ¼ 95Þ, stage II in 35% ðn ¼ 52Þ and stage III in 2%
ðn ¼ 3Þ according to the GOLD 2003. Adjusted
odds ratio was significant for smoking 430 pack-
years.
Conclusions: Our method to invite relatively young
smokers selected a population of smokers with a
high frequency of COPD. The method may be
one way to identify smokers with COPD at early
stages.
